Krisztina Ludasi
Overview
Explore the profile of Krisztina Ludasi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saker R, Regdon Jr G, Ludasi K, Sovany T
Pharmaceutics
. 2025 Jan;
17(1).
PMID: 39861695
Background: Nanotechnology has been the main area of focus for research in different disciplines, such as medicine, engineering, and applied sciences. Therefore, enormous efforts have been made to insert the...
2.
Ahmed Y, Mahmoud A, Ludasi K, Sovany T
Pharmaceuticals (Basel)
. 2024 Nov;
17(11).
PMID: 39598407
Background/objectives: Three-dimensional printing technology has emerging interest in pharmaceutical manufacturing, offering new opportunities for personalized medicine and customized drug delivery systems. Fused deposition modeling (FDM) is highly regarded in the...
3.
Mahmoud A, Hassan A, Dobo D, Ludasi K, Janovak L, Regdon Jr G, et al.
Pharmaceutics
. 2024 Jul;
16(7).
PMID: 39065545
The preparation of pellets using a high-shear granulator in a rapid single-step is considered a good economic alternative to the extrusion spheronization process. As process parameters and material attributes greatly...
4.
Kristo K, Modra S, Hornok V, Suvegh K, Ludasi K, Aigner Z, et al.
Pharmaceutics
. 2022 Feb;
14(2).
PMID: 35214077
Nowadays, the buccal administration of mucoadhesive films is very promising. Our aim was to prepare ascorbic acid-containing chitosan films to study the properties and structures important for applicability and optimize...
5.
Ludasi K, Jojart-Laczkovich O, Sovany T, Hopp B, Smausz T, Andrasik A, et al.
Int J Pharm
. 2021 Jun;
605:120793.
PMID: 34119582
Counterfeiting of the products for healing is as old as trading, and it is difficult to quantify the magnitude of the problem. It is known that substandard and/or falsified (SF)...
6.
Ludasi K, Jojart-Laczkovich O, Sovany T, Hopp B, Smausz T, Regdon Jr G
Int J Pharm
. 2019 Sep;
570:118665.
PMID: 31499234
Substandard and/or falsified medicines are a growing global threat for health and they cause serious social and economic damage. In low- and middle-income countries the failure rate of these medical...